Is advanced combination therapy effective in patients with refractory Inflammatory Bowel Disease?

被引：0
|
作者：
Gallardo, M. Rodriguez [1 ]
Delgado, T. Valdes [1 ]
Perez, B. Maldonado [1 ]
Jimenez, M. Belvis [1 ]
Paredes, A. Aguado [2 ]
Laria, L. Castro [1 ]
Arias, F. Arguelles
机构：
[1] Virgen Macarena Univ Hosp, Gastroenterol Dept, Seville, Spain
[2] Virgen Macarena Univ Hosp, Pharmacol Dept, Seville, Spain
来源：
JOURNAL OF CROHNS & COLITIS | 2025年 / 19卷
关键词：
D O I：
10.1093/ecco-jcc/jjae190.0775
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P0601
引用
收藏
页码：i1195 / i1196
页数：2
相关论文
共 50 条
  • [41] Combination Therapy in Pediatric Inflammatory Bowel Disease: Yes, No, Maybe
    Hyams, Jeffrey S.
    Kugathasan, Subra
    Dubinsky, Marla C.
    INFLAMMATORY BOWEL DISEASES, 2017, 23 (10) : 1774 - 1776
  • [42] Low Doses of Azathioprine are Effective in Combination With Infliximab in Inflammatory Bowel Disease but May not be During Induction Therapy
    Roblin, Xavier
    Flourie, B.
    Paul, Stephane
    JOURNAL OF CROHNS & COLITIS, 2018, 12 (05): : 628 - 628
  • [43] Reply to "Biologics Are Effective in the Management of Inflammatory Bowel Disease Following Liver Transplantation in Combination With Antirejection Therapy"
    Safarpour, Ali Reza
    Shojaei-Zarghani, Sara
    Mehrabi, Manoosh
    Keshtkar, Abbas Ali
    Oroojan, Ali Akbar
    Sivandzadeh, Gholam Reza
    INFLAMMATORY BOWEL DISEASES, 2022, 28 (12) : E153 - E153
  • [44] Effectiveness of darbepoetin alfa in combination with intravenous iron sucrose in patients with inflammatory bowel disease and refractory anemia
    Koutroubakis, Ioannis
    Karmins, Konstantmos
    Makreas, Sokratis
    Xidakis, Costas
    Tsiolakidou, Georgia
    Kouroumalis, Elias
    GASTROENTEROLOGY, 2006, 130 (04) : A202 - A202
  • [45] Mono vs Combination Ustekinumab Therapy in Inflammatory Bowel Disease
    Al Bawardy, Badr F.
    Petrov, Jessica C.
    Fine, Sean
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S392 - S393
  • [46] Combination Therapy With Methotrexate in Inflammatory Bowel Disease: Time to COMMIT?
    Narula, Neeraj
    Peyrin-Biroulet, Laurent
    Colombel, Jean-Frederic
    GASTROENTEROLOGY, 2014, 146 (03) : 608 - 611
  • [47] PATIENTS REPORT SEVERAL BARRIERS TO ADVANCED THERAPY INITIATION FOR MANAGEMENT OF INFLAMMATORY BOWEL DISEASE
    Cusumano, Vivy T.
    Spartz, Ellen
    Sauk, Jenny S.
    Limketkai, Berkeley N.
    GASTROENTEROLOGY, 2023, 164 (06) : S514 - S514
  • [48] Tacrolimus (FK506) is safe and effective in patients with refractory extraintestinal manifestations of inflammatory bowel disease
    Baumgart, Daniel C.
    Tanczos, Barbara T.
    Sturm, Andreas
    Wiedenmann, Bertram
    Dignass, Axel U.
    GASTROENTEROLOGY, 2006, 130 (04) : A660 - A660
  • [49] An immune therapy model for effective treatment on inflammatory bowel disease
    Park, Anna
    Kim, Sangil
    Jung, Il Hyo
    Byun, Jong Hyuk
    PLOS ONE, 2020, 15 (09):
  • [50] Management of refractory inflammatory bowel disease
    Gergely, Mate
    Prado, Eric
    Deepak, Parakkal
    CURRENT OPINION IN GASTROENTEROLOGY, 2022, 38 (04) : 347 - 357
12345